✦ LIBER ✦

Long-term follow-up of portacaval shunt in glycogen storage disease type 1B

✍ Scribed by Lucien Corbeel; Stefaan Van Lierde; Jaak Jaeken

Publisher: Springer
Year: 2000
Tongue: English
Weight: 93 KB
Volume: 159
Category: Article
ISSN: 0340-6997
DOI: 10.1007/s004310050068

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Haematological findings in type Ib glyco

Haematological findings in type Ib glycogen storage disease before and after portacaval shunt

✍ L. Corbeel; M. Boogaerts; G. Berghe; M. C. Everaerts; G. Marchal; R. Eeckels 📂 Article 📅 1983 🏛 Springer 🌐 English ⚖ 386 KB

Persistent neutropenia and repeated respiratory infections were documented in a girl with glycogen storage disease type Ib. A termino-lateral portacaval shunt resulted in normalisation of the granulocyte counts and disappearance of the recurrent infections. The platelet dysfunction that was apparent

Granulocyte colony-stimulating factor in

Granulocyte colony-stimulating factor in glycogen storage disease type 1b. Results of the European Study on Glycogen Storage Disease Type 1

✍ Gepke Visser; Jan Rake; Philippe Labrune; James V. Leonard; Shimon Moses; Kurt U 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 96 KB

The long-term outcome of patients with g

The long-term outcome of patients with glycogen storage disease type Ia

✍ G. P. A. Smit 📂 Article 📅 1993 🏛 Springer 🌐 English ⚖ 345 KB

Impairment of calcium mobilization in ph

Impairment of calcium mobilization in phagocytic cells in glycogen storage disease type 1b

✍ H. M. Korchak; B. -Z. Garty; C. A. Stanley; L. Baker; S. D. Douglas; L. Kilpatri 📂 Article 📅 1993 🏛 Springer 🌐 English ⚖ 482 KB

Postnatal regression of glucose transpor

Postnatal regression of glucose transport in a patient with glycogen storage disease type 1b

✍ J. Levy; M. T. Abu-Ras; T. Berenstein; R. Potashnik; I. Meisner; S. W. Moses; N. 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 420 KB

Long-term follow-up of impulse control d

Long-term follow-up of impulse control disorders in Parkinson's disease

✍ Eugenia Mamikonyan; Andrew D. Siderowf; John E. Duda; Marc N. Potenza; Stacy Hor 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB 👁 1 views

## Abstract Recent studies have linked dopamine agonist (DA) usage with the development of impulse control disorders (ICDs) in Parkinson's disease (PD). Little is known about optimal management strategies or the long‐term outcomes of affected patients. To report on the clinical interventions and lo